Q Fever News and Research

RSS

Scientists develop a smartwatch-based device for early detection of COVID-19

Scientists have developed a wearable device that can detect the early onset of COVID-19 in real-time by analyzing the aberrant changes in physiological parameters caused by SARS-CoV-2 infection.

30 Nov 2021

Many long-haul COVID-19 patients may experience breathing issues, chronic fatigue syndrome

Many long-haul COVID-19 patients have chronic fatigue syndrome and other breathing issues months after their initial COVID-19 diagnosis, according to study in JACC: Heart Failure, which is the first of its kind to identify a correlation between long-haul COVID-19 and chronic fatigue syndrome.

29 Nov 2021

Study: About 1 in 100 COVID-19 patients likely develop central nervous system complications

The largest multi-institutional international study to date on brain complications of COVID-19 has found that approximately one in 100 patients hospitalized with COVID-19 will likely develop complications of the central nervous system.

29 Nov 2021

Triple combination symptoms anosmia-fatigue-cough more specific to COVID-19 than single symptoms

In a research paper published in the journal PLOS ONE, the authors developed COVID–Online, a symptom checking application in Germany.

25 Nov 2021

Safety and immunogenicity of COVID-19 peptide vaccine

In a study published in Nature, researchers from University Hospital Tübingen have been investigating the results from a Phase I trial for a new vaccine against SARS-CoV-2 variants.

25 Nov 2021

Breakthrough infections from SARS-CoV-2 Delta variant among vaccinated healthcare workers

A new study published on the medRxiv* preprint server employed in-silico techniques, combining genomic and epidemiological data, to determine possible Delta-variant transmission events between vaccinated healthcare workers (HCWs) in Indian hospitals.

25 Nov 2021

Study shows risk of MIS-C post mRNA vaccination against COVID-19 in children with autoimmune complications

Researchers discuss two cases of MIS-V after the patients had received the SARS-CoV-2 vaccine from Pfizer/BioNTech (BNT162b2).

23 Nov 2021

Effectiveness of public health measures in reducing COVID-19 incidence

A new review suggests public health measures such as mask-wearing, universal lockdowns, and temporary shutdowns of businesses and schools helped prevent further SARS-CoV-2 transmission.

23 Nov 2021

Study shows porcine deltacoronavirus (PDCoV) is capable of zoonotic transfer

A team of researchers describes the presence of PDCoV strains in plasma samples of three Haitian children with acute undifferentiated febrile illness.

22 Nov 2021

Bioinformatics analysis identifies pathways involved in intestinal SARS-CoV-2 infection

Researchers recently used bioinformatics analysis techniques to explore the diseases caused by SARS-CoV-2 infection in the human digestive tract.

22 Nov 2021

Study finds no increased risk of severe COVID-19 in immunocompromised children in UK

Researchers conducted a prospective study to describe the incidence and clinical spectrum of SARS-CoV-2 infection in a UK-wide cohort of immunocompromised children.

22 Nov 2021

Sheep at low-risk for infection with SARS-CoV-2

A team of scientists from the US has recently evaluated the susceptibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in sheep. The findings reveal that sheep are generally less susceptible to SARS-CoV-2 infection. However, the susceptibility is relatively higher for the alpha variant of the virus. The study is currently available on the bioRxiv preprint server.

21 Nov 2021

CDC posts food safety alert about multistate outbreak of E. coli O157 infections linked to spinach

A CDC food safety alert regarding a multistate outbreak of E. coli O157 infections linked to spinach has been posted: https://www.cdc.gov/ecoli/2021/o157h7-11-21/index.html.

20 Nov 2021

First long-acting injectable HIV treatment appraised and approved by NICE

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi Limited as shareholders, is pleased to announce that eligible people living with Human Immunodeficiency Virus (HIV) in England and Wales will soon have routine access to Vocabria (cabotegravir long-acting injection) developed by ViiV Healthcare in combination with Rekambys (rilpivirine long-acting injection), developed by Janssen Sciences Ireland UC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

19 Nov 2021

The ER charged him $6,500 for six stitches. No wonder his critically ill wife avoided the ER.

Jason and DeeAnn Dean recently relocated to her hometown of Dellrose, Tennessee, where she grew up on a farm. Both in their late 40s, they're trying to start a green dream business that combines organic farming with a health and wellness consulting company.

19 Nov 2021

A covid head-scratcher: Why lice lurk despite physical distancing

The Marker family opened their door on a recent evening to a woman dressed in purple, with a military attitude to cleanliness.

19 Nov 2021

What is the global prevalence of long COVID?

This study aims to provide a comprehensive synthesis of information on the prevalence and symptoms of PASC.

18 Nov 2021

Long-term Pfizer vaccine-elicited SARS-CoV-2 antibody profile in breast milk

A new study indicates that the Pfizer vaccine induces antibodies in the breast milk against SARS-CoV-2.

17 Nov 2021

Clinically applicable strategy for early identification of IFN-AAB-positive COVID-19 patients

Researchers from the Humboldt-Universität zu Berlin have been investigating the presence of these antibodies in hospitalized COVID-19 patients to examine the potential of using them as a biomarker for severe disease.

17 Nov 2021

Prescription omega-3 pill did not reduce hospitalization or death from COVID-19

A high dose of a purified omega-3 fatty acid, available by prescription only, was well tolerated; however, it did not substantially reduce incidents of hospitalizations and/or deaths among people with COVID-19, according to a late-breaking clinical trial presented today at the American Heart Association's Scientific Sessions 2021.

15 Nov 2021

Q Fever News and Research

Scientists develop a smartwatch-based device for early detection of COVID-19

Many long-haul COVID-19 patients may experience breathing issues, chronic fatigue syndrome

Study: About 1 in 100 COVID-19 patients likely develop central nervous system complications

Triple combination symptoms anosmia-fatigue-cough more specific to COVID-19 than single symptoms

Safety and immunogenicity of COVID-19 peptide vaccine

Breakthrough infections from SARS-CoV-2 Delta variant among vaccinated healthcare workers

Study shows risk of MIS-C post mRNA vaccination against COVID-19 in children with autoimmune complications

Effectiveness of public health measures in reducing COVID-19 incidence

Study shows porcine deltacoronavirus (PDCoV) is capable of zoonotic transfer

Bioinformatics analysis identifies pathways involved in intestinal SARS-CoV-2 infection

Study finds no increased risk of severe COVID-19 in immunocompromised children in UK

Sheep at low-risk for infection with SARS-CoV-2

CDC posts food safety alert about multistate outbreak of E. coli O157 infections linked to spinach

First long-acting injectable HIV treatment appraised and approved by NICE

The ER charged him $6,500 for six stitches. No wonder his critically ill wife avoided the ER.

A covid head-scratcher: Why lice lurk despite physical distancing

What is the global prevalence of long COVID?

Long-term Pfizer vaccine-elicited SARS-CoV-2 antibody profile in breast milk

Clinically applicable strategy for early identification of IFN-AAB-positive COVID-19 patients

Prescription omega-3 pill did not reduce hospitalization or death from COVID-19

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News